We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPE
2101
DELISTED
Callon Petroleum Company
CPE
$23K ﹤0.01%
341
-733
-68% -$52.9K
BVH
2102
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$23K ﹤0.01%
968
-2,093
-68% -$53.5K
RST
2103
DELISTED
ROSETTA STONE INC
RST
$23K ﹤0.01%
+990
New +$23.8K
STML
2104
DELISTED
Stemline Therapeutics, Inc.
STML
$23K ﹤0.01%
+1,532
New +$22.2K
OILU
2105
DELISTED
ProShares UltraPro 3x Crude Oil ETF
OILU
$23K ﹤0.01%
1,031
+796
+339% +$21K
ELGX
2106
DELISTED
Endologix Inc
ELGX
$23K ﹤0.01%
+3,140
New +$21.4K
ADRE
2107
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$23K ﹤0.01%
572
QADA
2108
DELISTED
QAD Inc.
QADA
$23K ﹤0.01%
+567
New +$25.3K
CHL
2109
DELISTED
China Mobile Limited
CHL
$23K ﹤0.01%
509
-6,475
-93% -$301K
CHA
2110
DELISTED
China Telecom Corporation, LTD
CHA
$23K ﹤0.01%
+455
New +$23.3K
AVXL icon
2111
Anavex Life Sciences
AVXL
$310M
$22K ﹤0.01%
6,643
+3,313
+99% +$10.3K
DDS icon
2112
Dillards
DDS
$9.56B
$22K ﹤0.01%
+356
New +$22.9K
DTIL icon
2113
Precision BioSciences
DTIL
$207M
$22K ﹤0.01%
+56
New +$22.5K
EPC icon
2114
Edgewell Personal Care
EPC
$1.31B
$22K ﹤0.01%
828
-3,295
-80% -$117K
ESE icon
2115
ESCO Technologies
ESE
$7.92B
$22K ﹤0.01%
261
-711
-73% -$52.2K
FDUS icon
2116
Fidus Investment
FDUS
$772M
$22K ﹤0.01%
1,354
-1,365
-50% -$21.7K
INDY icon
2117
iShares S&P India Nifty 50 Index Fund
INDY
$569M
$22K ﹤0.01%
579
-378
-39% -$14.4K
KODK icon
2118
Kodak
KODK
$983M
$22K ﹤0.01%
9,172
+8,689
+1,799% +$21.5K
LSBK icon
2119
Lake Shore Bancorp
LSBK
$134M
$22K ﹤0.01%
1,445
+329
+29% +$4.98K
NEXA icon
2120
Nexa Resources
NEXA
$1.87B
$22K ﹤0.01%
2,214
+1,696
+327% +$18.3K
NL icon
2121
NLI Holdings
NL
$317M
$22K ﹤0.01%
5,900
+4,225
+252% +$15.4K
NVMI
2122
Nova
NVMI
$12.5B
$22K ﹤0.01%
888
+830
+1,431% +$22.2K
PARR icon
2123
Par Pacific Holdings
PARR
$3.32B
$22K ﹤0.01%
+1,057
New +$20.6K
PEBO icon
2124
Peoples Bancorp
PEBO
$1.47B
$22K ﹤0.01%
682
+404
+145% +$12.9K
PSCC icon
2125
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$41.7M
$22K ﹤0.01%
918
-3
-0.3% -$75

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.